Stocklytics Platform
Asset logo for symbol HOTH
Hoth Therapeutics
HOTH52
$0.85arrow_drop_up2.35%$0.01
Penny Stock
Asset logo for symbol HOTH
HOTH52

$0.85

arrow_drop_up2.35%
no data available for key stats

There's no data available for key stats

no data available for ratios/profitability stats

There's no data available for ratios/profitability stats

Fundamentals
Gross Profit-
Payout Ratio-
Industry average yield2.89%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

HOTH-
US Healthcare Sector-
US Market-
check_circle

HOTH / Market

HOTH exceeded the US Market which returned 0.03% over the last twenty four hours.
warning

HOTH / Healthcare Sector

HOTH lose to the US Healthcare sector which returned 2.60% over the last twenty four hours.

Hoth Therapeutics (HOTH) Statistics

Hoth Therapeutics Inc (HOTH) is a pharmaceutical company that focuses on the development of innovative therapies for dermatological conditions. The company is committed to providing novel treatments for patients suffering from various skin disorders. In order to evaluate the financial performance and valuation of Hoth Therapeutics Inc, it is important to analyze its stock statistics and fundamental metrics.
When considering the stock statistics of Hoth Therapeutics Inc (HOTH), it is crucial to look at its valuation metrics. These metrics help investors assess the intrinsic value of the company and determine if it is overpriced or undervalued in the market. Some important valuation metrics include the price-to-earnings ratio, price-to-sales ratio, and price-to-book ratio. These ratios provide insights into the company's financial health and growth potential.
add Hoth Therapeutics  to watchlist

Keep an eye on Hoth Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has Hoth Therapeutics (HOTH) stock's performance compared to its sector and the market over the past year?

Over the past year, Hoth Therapeutics (HOTH) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 15.12%, Hoth Therapeutics has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 23.87%, it has fallen short of the market average. This comparison highlights Hoth Therapeutics 's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Hoth Therapeutics (HOTH) stock?

The PE ratio for Hoth Therapeutics (HOTH) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help

What is the EPS of Hoth Therapeutics (HOTH) stock?

The Earnings Per Share (EPS) for Hoth Therapeutics (HOTH), calculated on a diluted basis, is -$1.27. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Hoth Therapeutics (HOTH) stock?

The operating margin for Hoth Therapeutics (HOTH) is 0%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Hoth Therapeutics (HOTH) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Hoth Therapeutics (HOTH) is $0. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Hoth Therapeutics (HOTH) have?

Hoth Therapeutics (HOTH) has a total debt of $33.81K. The net debt, which accounts for cash and cash equivalents against the total debt, is -$7.99M.

Take Your Investments to a Whole New Level